Ticker Symbol: CDXC
Chromadex Corp
$5.97 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
United States
Currency:
USD
Asset
Type: Common Stock
CIK:0001386570
Company Profile
ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of NAD and its impact on human health. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2833
Address: 10900 Wilshire Blvd Ste 600
Website: www.chromadex.com
CEO: Robert Fried
Tags:
- Process Industries
- Chemicals: Specialty
- Manufacturing
- Medicinal and Botanical Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $1.29
Change:
-
(
0.00%)
Days Range: $1.27 - $1.30
Beta: 1.15
52wk. High: $2.24
52wk. Low: $1.28
Ytd. Change -23.21%
50 Day Moving Average: $1.41
200 Day Moving Average: $1.51
Shares Outstanding: 75032367
Valuation
Market Cap: 9.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A